Spencer R. Berthelsen, Director at IONIS PHARMACEUTICALS INC (IONS), sold 15,000 shares at $37.74 ($566K) on 2021-06-23, disclosed to the SEC on 2021-06-25.
Seasonal sale ($566k) by Director — this insider has traded IONS in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2024-06-20 | $645K | — | Filing → |
| IONS | SELL | 2020-06-25 | $881K | — | Filing → |
| IONS | SELL | 2019-06-26 | $1.9M | — | Filing → |